Transforming Workforce Training Through Federal Leadership in XR Technology
Summary
Today’s unprecedented health and economic challenges demand a transformative approach to workforce training. Already, technology that immerses a person in a digital space (virtual reality) or that enhances reality with digital features (augmented reality) is making it possible to prepare workers faster and better for high-quality, high-demand jobs. Government investment in augmented and virtual reality (together known as “XR” technology) will supercharge workforce training, helping Americans across the country get into jobs that benefit them and our society.
The Federal Government should partner with industry to identify and implement “shovel-ready” applications of XR technology. Initial efforts should focus on demonstrating proof of concept by deploying XR technology towards two goals; namely:
- Work through the Department of Health and Human Services (HHS) to train 50,000 nurses over the next four years.
- Work through the Department of Labor (DOL) and Department of Energy (DOE) to train 50,000 solar-energy installers over the next four years.
These goals are readily achievable thanks to existing programmatic infrastructure at agencies with explicit workforce-development missions. Follow-on work could expand applications of XR technology to workforce training in other domains and/or through other agencies.
By structuring licensing-and-talent deals that replicate mergers while avoiding antitrust scrutiny, dominant technology firms are reshaping AI labor markets, venture financing, and the future of U.S. innovation.
It is in the interests of the United States to appropriately protect information that needs to be protected while maintaining our participation in new discoveries to maintain our competitive advantage.
Our analysis of federal AI governance across administrations shows that divergent compliance procedures and uneven institutional capacity challenge the government’s ability to deploy AI in ways that uphold public trust.
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.